Rosen LS - Search Results

1

Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars.

Rosen LS, Jacobs IA, Burkes RL. Rosen LS, et al. Target Oncol. 2017 Oct;12(5):599-610. doi: 10.1007/s11523-017-0518-1. Target Oncol. 2017. PMID: 28801849 Free PMC article. Review.

2

Targeting signal transduction pathways in metastatic breast cancer: a comprehensive review.

Rosen LS, Ashurst HL, Chap L. Rosen LS, et al. Oncologist. 2010;15(3):216-35. doi: 10.1634/theoncologist.2009-0145. Epub 2010 Mar 3. Oncologist. 2010. PMID: 20200040 Free PMC article. Review.

3

Endoglin for targeted cancer treatment.

Rosen LS, Gordon MS, Robert F, Matei DE. Rosen LS, et al. Curr Oncol Rep. 2014 Feb;16(2):365. doi: 10.1007/s11912-013-0365-x. Curr Oncol Rep. 2014. PMID: 24445497 Review.

4

Efficacy and safety of zoledronic acid in the treatment of bone metastases associated with lung cancer and other solid tumors.

Rosen LS. Rosen LS. Semin Oncol. 2002 Dec;29(6 Suppl 21):28-32. doi: 10.1053/sonc.2002.37416. Semin Oncol. 2002. PMID: 12584692 Review.

5

Overview of anti-VEGF therapy and angiogenesis. Part 1: Angiogenesis inhibition in solid tumor malignancies.

Ellis LM, Rosen L, Gordon MS. Ellis LM, et al. Clin Adv Hematol Oncol. 2006 Jan;4(1):suppl 1-10; quz 11-2. Clin Adv Hematol Oncol. 2006. PMID: 16562372

6

Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.

Rosen LS, Abdi E, Davis ID, Gutheil J, Schnell FM, Zalcberg J, Cesano A, Gayko U, Chen MG, Clarke S. Rosen LS, et al. J Clin Oncol. 2006 Nov 20;24(33):5194-200. doi: 10.1200/JCO.2005.04.1152. Epub 2006 Oct 30. J Clin Oncol. 2006. PMID: 17075109 Clinical Trial.

7

Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.

Saltz LB, Rosen LS, Marshall JL, Belt RJ, Hurwitz HI, Eckhardt SG, Bergsland EK, Haller DG, Lockhart AC, Rocha Lima CM, Huang X, DePrimo SE, Chow-Maneval E, Chao RC, Lenz HJ. Saltz LB, et al. Among authors: rosen ls. J Clin Oncol. 2007 Oct 20;25(30):4793-9. doi: 10.1200/JCO.2007.12.8637. J Clin Oncol. 2007. PMID: 17947727 Clinical Trial.

8

Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors.

Weekes CD, Rosen LS, Capasso A, Wong KM, Ye W, Anderson M, McCall B, Fredrickson J, Wakshull E, Eppler S, Shon-Nguyen Q, Desai R, Huseni M, Hegde PS, Pourmohamad T, Rhee I, Bessudo A. Weekes CD, et al. Among authors: rosen ls. Cancer Chemother Pharmacol. 2018 Aug;82(2):339-351. doi: 10.1007/s00280-018-3622-8. Epub 2018 Jun 15. Cancer Chemother Pharmacol. 2018. PMID: 29905898 Clinical Trial.

9

VEGF-targeted therapy: therapeutic potential and recent advances.

Rosen LS. Rosen LS. Oncologist. 2005 Jun-Jul;10(6):382-91. doi: 10.1634/theoncologist.10-6-382. Oncologist. 2005. PMID: 15967832 Free article. Review.

10

Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note.

Bilchik AJ, Poston G, Curley SA, Strasberg S, Saltz L, Adam R, Nordlinger B, Rougier P, Rosen LS. Bilchik AJ, et al. Among authors: rosen ls. J Clin Oncol. 2005 Dec 20;23(36):9073-8. doi: 10.1200/JCO.2005.03.2334. J Clin Oncol. 2005. PMID: 16361615 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page